Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, April, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca  ZD4054 Prostate cancer IMC Medical Communication
Celgene Vidaza Haematology Succinct Healthcare Communications
EMD Serono
n/a
Infertility Medaxial
Genzyme Mozobil Oncology Medaxial
Genzyme Thyrogen endocrinology / oncology
Medaxial
Lifeblood: The Thrombosis Charity
National Thrombosis Awareness Week
Corporate Athena
Napp Pharmaceuticals
Targinact Pain Flutter & Wow
Novartis
Exelon patch
Neuroscience
Just::
Novartis global
Stalevo
Neuroscience
Just::
Novartis Oncology International
Zometa
Oncology
PraeMedica
Sanofi-aventis/Bristol-Myers Squibb
n/a
Cardiovascular
Medaxial
SPD Development Company
Clearblue digital pregnancy test
Women's health
IMC Medical Communications
Wyeth ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

12th May 2009

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics